Luteinizing hormone compromises the in vivo anti-tumor sorted by
relevance

Admin17.08.2021

Luteinizing hormone compromises the in vivo anti-tumor

Admin13.08.2021

Luteinizing hormone compromises the in vivo anti-tumor

4006
Admin20.08.2021

Luteinizing hormone compromises the in vivo anti-tumor

7706
Admin09.08.2021

Luteinizing hormone compromises the in vivo anti-tumor

Admin03.10.2021

Luteinizing hormone compromises the in vivo anti-tumor

Admin12.07.2021

Luteinizing Hormone-Releasing Hormone (LHRH)-I Antagonist

Admin02.10.2021

The phosphorylation of the DNA breakdown marker, γ-H2AX

9103
Admin27.08.2021

(PDF) Targeted cytotoxic analog of luteinizing hormone

Admin15.07.2021

(PDF) Antitumor efficacy in rats of CGP 19984, a

1405
Admin16.07.2021

Inhibition of the growth of caki‐I human renal

4504
Admin29.09.2021

Luteinizing Hormone-Releasing Hormone (LHRH)-I Antagonist

3008
Admin20.08.2021

Effects of HCG on human epithelial ovarian cancer

5209
Admin25.09.2021

Inhibition of the growth of caki‐I human renal

Admin22.09.2021

(A) In vivo uptake of the BOEPL-L2-S0456 dye conjugate in

4808
Admin28.07.2021

Human Luteinizing Hormone ELISA Kit (A32993) | Antibodies.com

3708
Admin27.09.2021

Human Luteinizing Hormone ELISA Kit (A32993) | Antibodies.com

Admin27.09.2021

(PDF) Pharmacokinetics, distribution and anti-tumor

6010
Admin26.07.2021

[Full text] Characterization of luteinizing hormone

3809
Admin21.09.2021

Hematoxylin-eosin staining of adrenal tumors after

6401
Admin08.08.2021

Ov 90 | Bioz | Ratings For Life-Science Research

4505
Admin27.07.2021

(PDF) FSH in vitro versus LH in vivo: Similar genomic

3903